Technology | March 17, 2015

VuCOMP Announces FDA Approval of M-Vu CAD for Mammography Version 3.2

Latest version features increased sensitivity for improved mass detection

VuComp, M-Vu CAD, mammography, version 3.2

Image courtesy of VuComp Inc.

March 17, 2015 — VuComp Inc. announced that it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD (computer-aided detection) for mammography version 3.2. This latest version of the M-Vu CAD algorithm provides an increase in sensitivity, resulting in an improvement in mass detection performance.

The M-Vu CAD system was designed as a mammography CAD product to meet the rigorous FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.

In addition to M-Vu CAD, VuComp has developed and commercialized M-Vu Breast Density which received FDA market clearance in December 2013.

For more information: www.vucomp.com

Related Content

Older Biologic Age Linked to Elevated Breast Cancer Risk
News | Women's Health | March 19, 2019
Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according...
PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Hologic Earns CE Mark for LOCalizer Wireless Breast Lesion Localization System
News | Breast Imaging | March 07, 2019
Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast...
South Dakota's Density Inform Bill Signed Into Law
News | Breast Density | March 06, 2019
With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which...
iCAD Partnering With Karolinska Instituet Researchers on AI-based Breast Cancer Risk Prediction
News | Oncology Diagnostics | March 04, 2019
iCAD announced their intent to enter an exclusive relationship with two leading researchers at The Karolinska...

Image courtesy of Hologic.

Feature | Breast Imaging | February 27, 2019 | By Jeff Zagoudis